Partnership Between Premier’s ProvideGx™ Program and Exela Pharma Sciences, LLC, Successfully Resolves National Shortage of Cysteine Hydrochloride

Published on October 8, 2019

Premier's ProvideGx™ program and its partnership with Exela Pharma Sciences has successfully resolved the multi-year, national shortage of cysteine hydrochloride injection.